R1 RCM Inc

Apr 05 6:30am ET R1 RCM price target lowered to $15 from $17 at Guggenheim by TipRanks Apr 01 7:19am ET Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM) by TipRanks Mar 20 7:17am ET Truist Financial Sticks to Their Hold Rating for R1 RCM (RCM) by TipRanks Mar 20 7:03am ET R1 RCM price target lowered to $16 from $17 at Canaccord by TipRanks Mar 20 4:45am ET Buy Rating Affirmed for R1 RCM Amid Strong Fundamentals and Prospective Acquisition by TipRanks Mar 20 4:40am ET R1 RCM upgraded to Buy from Neutral at Citi by TipRanks Mar 19 9:10am ET LifeStance named Top Pick in Healthcare Technology at Morgan Stanley by TipRanks Mar 19 8:40am ET R1 RCM Committee says talks with New Mountain, TCP-ASC must stop for now by TipRanks Mar 13 2:11am ET Analysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Merck & Company (MRK) by TipRanks Mar 11 9:50pm ET Analysts Offer Insights on Healthcare Companies: Maravai Lifesciences Holdings (MRVI) and R1 RCM (RCM) by TipRanks Mar 11 9:35am ET Hold Rating on R1 RCM Amid Acquisition Talks and Valuation Considerations by TipRanks Mar 11 8:22am ET R1 RCM forms special committee to evaluate strategic alternatives by TipRanks Mar 11 12:35am ET R1 RCM Poised for Growth: Outperform Rating and $17 Target Justified by Strong LBO Potential and Historical Multiples by TipRanks Mar 04 5:35pm ET Maintaining Hold on R1 RCM Amid Acquisition Proposal and Mixed Financial Outlook by TipRanks Mar 04 5:29pm ET R1 RCM downgraded to Hold from Buy at Truist by TipRanks Mar 01 6:30am ET R1 RCM downgraded to Neutral from Buy at Citi by TipRanks Mar 01 1:17am ET Buy Rating Affirmed on R1 RCM Amid Strong Q4 Performance and Pragmatic FY2024 Outlook by TipRanks Feb 28 10:20am ET Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), uniQure (QURE) by TipRanks Feb 28 7:47am ET TD Cowen Keeps Their Buy Rating on R1 RCM (RCM) by TipRanks Feb 28 4:48am ET R1 RCM downgraded to Equal Weight from Overweight at Barclays by TipRanks Feb 27 11:38pm ET Buy Rating Justified: R1 RCM’s Undervalued Growth Potential and Market Position Strength by TipRanks Feb 27 4:05pm ET R1 RCM downgraded to In Line from Outperform at Evercore ISI by TipRanks Feb 27 4:05pm ET R1 RCM downgraded to In Line from Outperform at Evercore ISI by TipRanks Feb 27 7:12am ET R1 RCM to Discuss Quarterly and Annual Financial Results by TipRanks Feb 27 7:04am ET R1 RCM sees FY24 revenue $2.625B-$2.675B, consensus $2.69B by TipRanks Feb 27 7:03am ET R1 RCM reports Q4 EPS 0c, consensus 2c by TipRanks Feb 27 3:30am ET Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Elanco Animal Health (ELAN) and R1 RCM (RCM) by TipRanks Feb 26 4:15pm ET R1 RCM Hold Rating Justified Amid Buyout Proposal and Market Dynamics by TipRanks Feb 26 4:06pm ET R1 RCM downgraded to Hold from Buy at Deutsche Bank by TipRanks Feb 26 3:58pm ET Coliseum Capital says New Mountain bid indication undervalues R1 RCM by TipRanks Feb 26 1:53pm ET RBC says $13.75 a ‘reasonable starting point,’ R1 RCM fair value closer to $19 by TipRanks